PPT-Doxorubicin (3h): - -

Author : luanne-stotts | Published Date : 2018-02-18

WT A7 D7 Doxorubicin FlagFOXO3a FOXM1 p27Kip1 Tubulin FlagFOXO3a MCF7 MCF7 PFOXO3a Ser7 FlagFOXO3a p27Kip1 Cyclin E Bim XL Tubulin 0 3 9 24 0 3 9 24 0

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Doxorubicin (3h): - -" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Doxorubicin (3h): - -: Transcript

WT A7 D7 Doxorubicin FlagFOXO3a FOXM1 p27Kip1 Tubulin FlagFOXO3a MCF7 MCF7 PFOXO3a Ser7 FlagFOXO3a p27Kip1 Cyclin E Bim XL Tubulin 0 3 9 24 0 3 9 24 0. Sant. Chawla, M.D.. Director, Sarcoma Oncology Center. Santa Monica, California. Financial Disclosures . Advisor, Research Support, and Travel Grant. CytRx. Threshold Pharmaceuticals. GlaxoSmithKline. Sigrun Hallmeyer, MD. Oncology Specialists, SC. Director, Oncology Specialists Research Institute. Chair, Cancer Committee ALGH. Primary goals of systemic treatment for metastatic breast cancer. Prolongation of survival,. Principles of Chemotherapy. Wendy Blount, DVM. Indications for Chemotherapy. Systemic or metastatic disease that is chemo responsive. local control (surgery, radiation therapy) isn’t adequate . Cure is rare (TVT is an exception). MICROTEACHING. . Sanjeev Sharma. 2-3-2010 . Cancer cell and Chemotherapy. In which phase of cell cycle DNA replication occurs ?. CANCER CHEMOTHERAPY. Background . Cell cycle kinetics . Toxicity of anti-. neoplastic. drugs. Principles of combination therapies. Mechanisms of anti-. neoplastic. drugs. Classification of anticancer drugs. PI Wilms #1 Protocol . Dr Jane Skeen. . Wilms Tumour. . mostly unilateral painless abdominal mass + / - . haematuria. treatment. surgery. chemotherapy (+ / - radiotherapy stages III/IV). Overview: Company & Transcend Platform . biOasis. Technologies Inc. . biOasis . Technologies, . Inc. . (OTCQX:BIOF & TSX. -V:BTI) is a publically traded . biopharmaceutical company focused . first thing that the general medical oncologist has to realize is that the parallel word to sarcoma is actually carcinoma, not, say, breast cancer or lung . cancer. . Sarcomas . represent a group of up to 100 different diseases. EXTRAVASATION AND TISSUE NECROSIS, and SEVERE MYELOSUPPRESSION See full prescribing information for complete boxed warning. Cardiomyopathy: Myocardial damage can occur with doxorubicin HCl with inc PRINCIPLES OF CHEMOTHERAPY IN CANCER Prof. N. PAVLIDIS DISCLOSURE OF INTEREST Nothing to declare HISTORY OF CHEMOTHERAPY THROUGH THE YEARS The First Chemotherapeutic Agent Found • On Epigeneticdysregulationiscommonincancerandit involves,amongothermechanisms,aberrantpatternsof gene-specificDNAmethylation,DNAhydroxymethyla- tion,andgenome-widehypomethylation[1].Hypermethy- lationofp ADR-P03 ADRIAMYCIN (DOXOrubicin HCl) for Injection, USP ADRIAMYCIN (DOXOrubicin HCl) Injection, USP For Intravenous Use Only Rx ONLY WARNINGS 1. DOSAGE AND ADMINISTRA TION 2. Myocardi Osteogenic. sarcoma protocol. Osteosarcoma. 1. Meyers PA, . Gorlick. R. . Pediatr. . Clin. North Am 1997;44(4):973-990. . 2. . Bone sarcomas: ESMO Clinical Practice Guidelines. Ann . Oncol. 2014; 25(3): iii113-iii123. 3. . “old” chemosensitizers, “new” immune-sensitizers. Martina Godel. SIC Conference – Virtual Event. 27. th. -28. th. October 2021. 1. P-. glycoprotein. and . resistance. to . chemotherapy.

Download Document

Here is the link to download the presentation.
"Doxorubicin (3h): - -"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.